Back to Search
Start Over
LONG-TERM DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN TYPE 2 PATIENTS WITH/WITHOUT ALLERGIC.
- Source :
- Annals of Allergy, Asthma & Immunology; 2022 Supplement, Vol. 129 Issue 5, pS44-S45, 2p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 10811206
- Volume :
- 129
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Annals of Allergy, Asthma & Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 159656757
- Full Text :
- https://doi.org/10.1016/j.anai.2022.08.628